Clinical Trial Update: Study to Evaluate VORTX Rx (Theresa) [NA]

View source ↗

Summary

Completed clinical trial update for VORTX Rx (Theresa) evaluating hepatocellular carcinoma with liver metastases; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• VORTX Rx (Theresa) (Theresa)

Snippet

Sponsor: HistoSonics, Inc. | Conditions: Carcinoma, Hepatocellular, Liver Metastases | NA | Status: COMPLETED | Results posted: 2021-02-25